Are Ureaplasma urealyticum and Lactobacillus iners normal bacterial flora found in the vagina?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vaginal Flora Status of Ureaplasma urealyticum and Lactobacillus iners

Lactobacillus iners is part of normal vaginal flora but provides less protection than other Lactobacillus species, while Ureaplasma urealyticum is a commensal organism commonly found in healthy women but can act as an opportunistic pathogen under certain conditions.

Lactobacillus iners: A Normal but Less Protective Commensal

Prevalence and Classification

  • L. iners is one of the most frequently isolated Lactobacillus species from healthy human vaginas, alongside L. crispatus, L. gasseri, and L. jensenii 1
  • In reproductive-age women, there is typically a predominance of one or more Lactobacillus species, with L. iners being among the most common 2

Clinical Significance and Limitations

  • L. iners becomes the dominant species following standard metronidazole treatment for bacterial vaginosis, which likely contributes to the high recurrence rates (50-80% within one year) 3
  • While L. iners can maintain acidic vaginal pH similar to more protective species like L. crispatus, vaginal pH testing alone cannot distinguish between these communities 3
  • The selection of L. crispatus over L. iners for probiotic development reflects that natural predominance does not equal protective capacity 3

Ureaplasma urealyticum: A Common Commensal with Pathogenic Potential

Colonization Rates in Healthy Women

  • U. urealyticum may be found in the vagina/cervix of 40-80% of sexually mature women 4
  • In a longitudinal study of healthy women, U. urealyticum was isolated intermittently in 40% of women with bacterial vaginosis, 25% with candida, and 50% with normal microscopy 5

Pathogenic Role

  • U. urealyticum is recognized as a potential etiologic agent in pelvic inflammatory disease (PID), though it is not classified among the primary sexually transmitted organisms like N. gonorrhoeae and C. trachomatis 6
  • The organism exists as part of the vaginal flora but can cause disease under certain circumstances, particularly when ascending to the upper genital tract 6

Clinical Implications

Interpretation of Positive Findings

  • Finding U. urealyticum on a single occasion in asymptomatic women may not be clinically significant, as it can be part of normal intermittent colonization 5
  • Treatment is indicated when U. urealyticum is associated with clinical syndromes such as PID or when symptoms are present 7, 8

Treatment Considerations When Indicated

  • Doxycycline 100 mg orally twice daily for 7 days is the first-line treatment when U. urealyticum infection requires therapy 7, 8
  • Azithromycin 1 g orally in a single dose is an alternative, particularly when compliance concerns exist 7, 8
  • Sexual partners should be evaluated and treated, with abstinence from sexual intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen 7, 8

Common Pitfalls to Avoid

  • Do not automatically treat asymptomatic colonization with U. urealyticum, as it may represent normal flora rather than infection 5
  • Do not assume that L. iners-dominated flora provides the same protection as L. crispatus-dominated flora, despite both maintaining acidic pH 3
  • Symptoms correlate poorly with microbiological findings, so clinical context is essential for interpretation 5

References

Research

New findings about vaginal bacterial flora.

Revista da Associacao Medica Brasileira (1992), 2010

Guideline

Clinical Significance of Lactobacillus iners in Vaginal Health

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

What is normal vaginal flora?

Genitourinary medicine, 1997

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ureaplasma Infection Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Mycoplasma genitalium and Ureaplasma Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.